CN Patent

CN102573475B — 神经激肽-1拮抗剂的静脉内制剂

Assigned to Opko Health Inc · Expires 2016-01-20 · 10y expired

What this patent protects

本文描述了用于静脉内给药的药用组合物，其包含式I化合物或其药学上可接受的盐、水合物或前药。本文还描述了制备该药用组合物的方法和用该药用组合物治疗恶心和/或呕吐的方法。

USPTO Abstract

本文描述了用于静脉内给药的药用组合物，其包含式I化合物或其药学上可接受的盐、水合物或前药。本文还描述了制备该药用组合物的方法和用该药用组合物治疗恶心和/或呕吐的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN102573475B
Jurisdiction: CN
Classification: —
Expires: 2016-01-20
Drug substance claim: No
Drug product claim: No
Assignee: Opko Health Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.